C11H12ClN3O2
Neat
253.69
1236033-21-8; tert-Butyl 4-chloro-7H-pyrrolo[2, 3-d]pyrimidine-7-carboxylate; tert-butyl 4-chloropyrrolo[2, 3-d]pyrimidine-7-carboxylate; MFCD18427890; t-Butyl 4-chloropyrrolo[2, 3-d]pyrimidine-7-carboxylate; tert-Butyl 4-chloro-7H-pyrrolo-[2, 3-d]pyrimidine-7-carboxylate; 7H-Pyrrolo[2, 3-d]pyrimidine-7-carboxylic acid, 4- chloro-, 1, 1-dimethylethyl ester; Baricitinib Impurity 38; Tofacitinib Impurity 270; SCHEMBL3708799; SCHEMBL29706193; XGGUTWYJGILAOA-UHFFFAOYSA-N; AKOS025395294; AS-3206; PB48116; SY309928; DB-195668; 7-Boc-4-chloro-7H-pyrrolo[2 and 3-d]pyrimidine; E80391; F826461
tert-butyl 4-chloropyrrolo[2 and 3-d]pyrimidine-7-carboxylate
InChI=1S/C11H12ClN3O2/c1-11(2,3)17-10(16)15-5-4-7-8(12)13-6-14-9(7)15/h4-6H,1-3H3